Analysts Set Bath & Body Works, Inc. (NYSE:BBWI) PT at $23.53

Shares of Bath & Body Works, Inc. (NYSE:BBWI) have earned an average rating of “Hold” from the eighteen ratings firms that are presently covering the stock, Marketbeat reports. Thirteen investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year target price among brokerages that have covered the stock in the last year is $23.5333.

Several analysts have recently commented on the stock. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a research report on Wednesday, November 12th. Wells Fargo & Company cut their price target on Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, November 21st. Telsey Advisory Group cut Bath & Body Works from an “outperform” rating to a “market perform” rating and decreased their price target for the company from $38.00 to $17.00 in a report on Friday, November 21st. New Street Research set a $26.00 price objective on Bath & Body Works in a research report on Monday, November 24th. Finally, Morgan Stanley reiterated an “equal weight” rating and set a $18.00 target price (down previously from $43.00) on shares of Bath & Body Works in a research report on Friday, November 21st.

Bath & Body Works News Summary

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Zacks upgraded BBWI from “strong sell” to “hold,” which could temper selling pressure by some investors. Zacks Upgrade
• Neutral Sentiment: Brokerage consensus remains a “hold,” indicating analysts are not broadly bullish despite volatility. Consensus Hold
• Negative Sentiment: Multiple national law firms have filed or announced investigations and are soliciting lead plaintiffs in a securities‑class action alleging material misstatements/omissions covering June 4, 2024–Nov. 19, 2025 — raising the prospect of litigation costs, management distraction and reputational damage. Schall Law Firm Notice
• Negative Sentiment: Bleichmar Fonti & Auld and other firms cite a significant prior stock drop (reports reference a ~24% plunge) tied to the alleged disclosures, and are urging investors to contact counsel — this amplifies near‑term selling and uncertainty. BFA Fraud Alert
• Negative Sentiment: Additional plaintiff firms (Kessler Topaz, Rosen, Levi & Korsinsky, Bragar, Pomerantz, Faruqi, Kaplan Fox, and others) have issued alerts and deadline reminders for lead‑plaintiff motions (mid‑March deadlines), signaling broad, coordinated litigation activity. Kessler Topaz Alert

Insider Activity at Bath & Body Works

In related news, Director Francis Hondal bought 3,343 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was purchased at an average price of $14.99 per share, for a total transaction of $50,111.57. Following the completion of the transaction, the director owned 21,554 shares in the company, valued at $323,094.46. The trade was a 18.36% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Lucy Brady bought 3,470 shares of the business’s stock in a transaction that occurred on Friday, November 21st. The shares were bought at an average cost of $14.40 per share, with a total value of $49,968.00. Following the completion of the purchase, the director directly owned 17,482 shares of the company’s stock, valued at $251,740.80. This represents a 24.76% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders acquired 33,513 shares of company stock valued at $500,442. Corporate insiders own 0.27% of the company’s stock.

Institutional Investors Weigh In On Bath & Body Works

Institutional investors have recently modified their holdings of the stock. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in shares of Bath & Body Works during the second quarter valued at $33,000. First Horizon Corp bought a new position in Bath & Body Works during the 3rd quarter worth about $29,000. Geneos Wealth Management Inc. increased its position in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares during the period. Parallel Advisors LLC increased its position in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after purchasing an additional 481 shares during the period. Finally, Danske Bank A S bought a new stake in shares of Bath & Body Works in the 3rd quarter valued at about $39,000. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Stock Down 1.8%

BBWI stock opened at $22.17 on Friday. The business’s 50-day moving average price is $20.14 and its 200-day moving average price is $25.06. The stock has a market cap of $4.54 billion, a P/E ratio of 6.82, a PEG ratio of 0.81 and a beta of 1.51. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $41.87.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Thursday, November 20th. The company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.40 by ($0.05). Bath & Body Works had a negative return on equity of 47.35% and a net margin of 9.50%.The firm had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the company posted $0.49 earnings per share. The company’s revenue was down 1.0% compared to the same quarter last year. Bath & Body Works has set its FY 2025 guidance at 2.870- EPS and its Q4 2025 guidance at 1.700- EPS. On average, equities research analysts expect that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Friday, November 21st were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 3.6%. The ex-dividend date was Friday, November 21st. Bath & Body Works’s dividend payout ratio is presently 24.62%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.